financetom
Business
financetom
/
Business
/
Atmus Filtration Technologies Q4 Adjusted Earnings, Revenue Increase; 2025 Guidance Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atmus Filtration Technologies Q4 Adjusted Earnings, Revenue Increase; 2025 Guidance Issued
Feb 21, 2025 4:29 AM

07:04 AM EST, 02/21/2025 (MT Newswires) -- Atmus Filtration Technologies ( ATMU ) reported Q4 adjusted earnings Friday of $0.58 per diluted share, up from $0.49 a year earlier.

Analysts polled by FactSet expected $0.53.

Revenue for the quarter ended Dec. 31 was $406.7 million, up from $399.7 million a year earlier.

Analysts surveyed by FactSet expected $399.2 million.

For 2025, the industrial filtration and chemical products provider expects adjusted EPS of $2.35 to $2.60 on revenue of $1.67 billion to $1.74 billion. Analysts polled by FactSet expect non-GAAP EPS of $2.53 on revenue of $1.71 billion.

Shares of the company were up more than 7% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Blackstone Plans Debt Sale of Up to $668.5 Million Tied to UK Warehouses
Market Chatter: Blackstone Plans Debt Sale of Up to $668.5 Million Tied to UK Warehouses
Sep 2, 2025
07:06 AM EDT, 09/02/2025 (MT Newswires) -- Blackstone (BX) plans a debt sale of as much as 500 million British pounds ($668.5 million) tied to UK warehouses, Bloomberg News reported Tuesday, citing people familiar with the matter. The private-equity giant aims to sell commercial mortgage-backed securities as early as in September using assets managed by its Indurent industrial and logistics...
Cigna's Evernorth invests $3.5 billion in Shields
Cigna's Evernorth invests $3.5 billion in Shields
Sep 2, 2025
Sept 2 (Reuters) - Cigna Group's ( CI ) unit Evernorth Health on Tuesday said it is investing $3.5 billion in specialty pharmacy company Shields Health. (Reporting by Sriparna Roy in Bengaluru; Editing by Mrigank Dhaniwala) ...
Winklevoss twins-backed Gemini targets $2.2 billion valuation in US IPO
Winklevoss twins-backed Gemini targets $2.2 billion valuation in US IPO
Sep 2, 2025
Sept 2 (Reuters) - Gemini is seeking a valuation of up to $2.22 billion in its U.S. initial public offering, the cryptocurrency exchange said on Tuesday, following a blockbuster debut by rival Bullish earlier this year. The company, backed by billionaire twins Cameron and Tyler Winklevoss, plans to sell 16.67 million shares at $17 to $19 each, raising as much...
Organon, Henlius Says US FDA Approves Denosumab Biosimilars
Organon, Henlius Says US FDA Approves Denosumab Biosimilars
Sep 2, 2025
07:07 AM EDT, 09/02/2025 (MT Newswires) -- Organon (OGN) and Shanghai Henlius Biotech said Tuesday the US Food and Drug Administration has approved Bildyos 60 mg/mL injection and Bilprevda 120 mg/1.7 mL injection, denosumab biosimilars to Prolia and Xgeva used in the prevention of skeletal-related events in certain cancer patients. The companies said the approvals cover all indications of the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved